The present invention relates to the stable oral pharmaceutical composition with improved solubility and bioavailability; comprising of taxoid, solubilizer, stabilizing agent, surfactant(s), solvent(s), and oil wherein the concentration of taxoid is in the range of 0.1 to 10%.